Allarity Therapeutics, Inc. (NASDAQ: ALLR) reported Q1 EPS of ($0.25), $7.63 better than the analyst estimate of ($7.88).

For earnings history and earnings-related data on Allarity Therapeutics, Inc. (ALLR) click here.